High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon

Journal of Medical Virology

Volumn 80, Issue 9, 2008, Pages 1581-1587

  Ndong Atome, G R ^a,b   Makuwa, M ^a   Ouwe Missi Oukem Boyer, O ^a,f   Pybus, O G ^c   Branger, M ^d   Le Hello, S ^a,g   Boye Cheik, S B ^b   Brun Vezinet, F ^d   Kazanji, M ^a   Roques, P ^a,e   Bisser, S ^a,h  

^a Centre International de Recherches Médicales Franceville CIRMF   (Gabon)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d BICHAT HOSPITAL   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^f Laboratory of Systems Biology   (Cameroon)

^g Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^h UNIVERSITÉ DE LIMOGES   (France)

Author keywords

5 UTR; Central Africa; Genotype 4; HCV molecular epidemiology; NS5B

Indexed keywords

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; BACTERIAL GENOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; RURAL AREA; SCREENING TEST; SEROPREVALENCE; SEX RATIO; VIRUS GENE; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

HEPATITIS C VIRUS;

EID: 48249137277     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21252     Document Type: Article

References (48)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
2. Basaras M, Santamaria A, Sarsa M, Gutierrez E, de Olano Y, Cisterna R. 1999. Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea. Trans R Soc Trop Med Hyg 93:250-252.
3. Bukh J, Purcell RH, Miller RH. 1992. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187-191.
4. Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. 2007. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: An update and report of a new method of HCV genotyping. Anticancer Res 27:1219-1222.
5. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
6. Delaporte E, Thiers V, Dazza MC, Romeo R, Mlika-Cabanne N, Aptel I, Schrijvers D, Brechot C, Larouze B. 1993. High level of hepatitis C endemicity in Gabon, equatorial Africa. Trans R Soc Trop Med Hyg 87:636-637.
7. Delaporte E, Froment A, Dazza MC, Henzel D, Larouze B. 1994. Hepatitis C in remote populations of southern Cameroon. Ann Trop Med Parasitol 88:97-98.
8. Dokekias AE, Okandze-Elenga JP, Kinkouna AG, Lepfoundzou AB, Garcia S. 2003. Seroprevalence of viral hepatitis C in polytransfused patients at Central University Hospital of Brazzaville. Bull Soc Pathol Exot 96:279-282.
9. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214.
10. Echevarria JM, Leon P, Pozo F, Avellon A. 2006. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin 24:20-225.
11. Fretz C, Jeannel D, Stuyver L, Herve V, Lunel F, Boudifa A, Mathiot C, de The G, Fournel JJ. 1995. HCV infection in a rural population of the Central African Republic (CAR): Evidence for three additional subtypes of genotype 4. J Med Virol 47:435-437.
12. Fried MW. 2004. Viral factors affecting the outcome of therapy for chronic hepatitis C. Rev Gastroenterol Disord 4:S8-S13.
13. Gisselquist D. 2003. Emergence of the HIV type 1 epidemic in the twentieth century: Comparing hypotheses to evidence. AIDS Res Hum Retroviruses 19:1071-1078.
14. Halfon P, Neumann AU, Bourliere M, Rieu A, Chadapaud S, Khiri H, Ouzan D, Cacoub P. 2003. Slow viral dynamics of hepatitis C virus genotype 4. J Viral Hepat 10:351-353.
15. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, Mele A, Giampaoli S, Rapicetta M. 2002. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50:693-696.
16. Kuiken C, Yusim K, Boykin L, Richardson R, 2005. The Los Alamos hepatitis C sequence database. Bioinformatics 21:379-384.
17. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, Gaudy C, Pawlotsky JM, Plantier JC, Pozzetto B, Thibault V, Tosetti F, Lefrere JJ. 2005. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 43:733-739.
18. Lindenbach BD, Rice CM. 2005. Unravelling hepatitis C virus replication from genome to function. Nature 933-938.
19. Louis FJ, Maubert B, Le Hesran JY, Kemmegne J, Delaporte E, Louis JP. 1994. High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area. Trans R Soc Trop Med Hyg 88:53-554.
20. Madhava V, Burgess C, Drucker E. 2002. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2:293-302.
21. Matera G, Lamberti A, Quirino A, Foca D, Giancotti A, Barreca GS, Guadagnino V, Liberto MC. 2002. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis 42:169-173.
22. Mencarini P, De Luca A, Antinori A, Maiuro G, Spedini G, Bailly C, Tamburrini E. 1991. Prevalence of anti-HCV antibodies in Cameroon. Trans R Soc Trop Med Hyg 85:654-655.
23. Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, Bentata M, Jarrousse B, Lortholary O, Pallier C, Deny P. 2001. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82:1001-1012.
24. Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B. 2002. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J Med Virol 66:179-186.
25. Nerrienet E, Pouillot R, Lachenal G, Njouom R, Mfoupouendoun J, Bilong C, Mauclere P, Pasquier C, Ayouba A. 2005. Hepatitis C virus infection in Cameroon: A cohort-effect. J Med Virol 76:208-214.
26. Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J. 2005. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol 86:107-114.
27. Njouom R, Pasquier C, Ayouba A, Gessain A, Froment A, Mfoupouendoun J, Pouillot R, Dubois M, Sandres-Saune K, Thonnon J, Izopet J, Nerrienet E. 2003a. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71:219-225.
28. Njouom R, Pasquier C, Ayouba A, Sandres-Saune K, Mfoupouendoun J, Mony Lobe M, Tene G, Thonnon J, Izopet J, Nerrienet E. 2003b. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: Prevalence, viremia, and genotypes. J Med Virol 69:384-390.
29. Njouom R, Nerrienet E, Dubois M, Lachenal G, Rousset D, Vessiere A, Ayouba A, Pasquier C, Pouillot R. 2007. The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 7:361-367.
30. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, van der Groen G, Ndumbe P. 1995. A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg 52:98-100.
31. Ogata N, Alter HJ, Miller RH, Purcell RH. 1991. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392-3396.
32. Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre MT, Vessiere A, Timba I, Thonnon J, Izopet J, Nerrienet E. 2005. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77:390-398.
33. Prevention. 2003. Guidelines for laboratory testing and result reporting of antibody to hepatitis C. Center for Control and Prevention. MMWR Recomm Rep 52:1-13.
34. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. 2001. The epidemic behaviour of the hepatitis C virus Science. 292:2323-2325.
35. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. 2003. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypte: A Bayesian coalescent approach. Mol Biol Evol 20:381-387.
36. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
37. Schijman A, Colina R, Mukomolov S, Kalinina O, Garcia L, Broor S, Bhupatiraju AV, Karayiannis P, Khan B, Mogdasy C, Cristina J. 2004. Comparison of bepatitis C viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol 11:433-435.
38. Schott E, Witt H, Hinrichsen H, Newmann K, Weich V, Bergk A, Halangk J, Muler T, Tinjala S, Puhl G, Neuhaus P, Wiedenmann B, Berg T. 2007. Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection. J Hepatol 46:372-380.
39. Shepard C, Finelli L, Alter M. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567.
40. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399.
41. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
42. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. 1997. The origin of hepatitis C virus genotypes. J Gen Virol 78:321-328.
43. Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. 1994. Classification of hepatitis C viruses bases on phylogenetic analysis of the envelope 1 and non strucural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 91:10134-10138.
44. Stuyver L, Wyseur A, Van Arnhem W, Hernandez F, Maertens G. 1996. Second-genotyping line probe assay for hepatitis C virus genotyping. J Clin Microbiol 34:2259-2266.
45. Swofford DL. 2002. PAUP*. Phylogenetic Analysis Using Parcimony (*and Other Methods). Version 4, Sunderland, Massachusetts.
46. Uto H, Hayashi K, Kusumoto K, Hasuike S, Nagata K, Kodama M, Ido A, Kohara M, Stuver SO, Tsubouchi H. 2006. Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatol Res 34:28-34.
47. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 189:292-302.
48. Xu LZ, Larzul D, Delaporte E, Brechot C, Kremsdorf D. 1994. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol 75:2393-2398.